{"DataElement":{"publicId":"3474983","version":"1","preferredName":"Gynecologic Fallopian Tube Tumor Federation of Gynecology and Obstetrics (FIGO) 2009 Stage","preferredDefinition":"Anatomic extent of the primary fallopian tube carcinoma based on surgical pathologic examination.","longName":"3474754v1.0:3474950v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"3474754","version":"1","preferredName":"Gynecologic Neoplasm Fallopian Tube Stage","preferredDefinition":"Of or relating to or practicing gynecology; pertaining to the health issues of women._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._One of a pair of tubes that extend from the uterus to each of the ovaries. Following ovulation the egg travels down the fallopian tube to the uterus where fertilization may or may not occur._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"2206690v1.0:3474752v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2206690","version":"1","preferredName":"Gynecologic Neoplasm","preferredDefinition":"Of or relating to or practicing gynecology; pertaining to the health issues of women.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C28016:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gynecologic","conceptCode":"C28016","definition":"Of or relating to or practicing gynecology; pertaining to the health issues of women.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-0016-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3474752","version":"1","preferredName":"Fallopian Tube Stage","preferredDefinition":"One of a pair of tubes that extend from the uterus to each of the ovaries. Following ovulation the egg travels down the fallopian tube to the uterus where fertilization may or may not occur.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C12403:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fallopian Tube","conceptCode":"C12403","definition":"One of a pair of tubes that extend from the uterus to each of the ovaries. Following ovulation the egg travels down the fallopian tube to the uterus where fertilization may or may not occur.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1BCD499-AFE7-5A2B-E040-BB89AD430F02","latestVersionIndicator":"Yes","beginDate":"2012-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1BCD499-AFF8-5A2B-E040-BB89AD430F02","latestVersionIndicator":"Yes","beginDate":"2012-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created for CRF standard harmonization. Released per request by D.Reeves. mc 6/5/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3474950","version":"1","preferredName":"Fallopian Tube Carcinoma Federation of Gynecology and Obstetrics (FIGO) 2009 Stage","preferredDefinition":"A carcinoma arising from the fallopian tube which is attached to the uterine corpus (uterine body). Most patients are postmenopausal, and postmenopausal bleeding is the most frequently seen symptom. Morphologically, the majority of fallopian tube carcinomas are serous or endometrioid adenocarcinomas._An international organization with a mission to promote the wellbeing of women and to raise the standards of practice in obstetrics and gynecology. They are the creator of staging criteria to describe the extent and spread of gynecologic malignancies._A number with no fractional part, including the negative and positive numbers as well as zero.::2009_The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3474950v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IV","valueDescription":"Fallopian Tube Cancer pM1 TNM Finding v7","ValueMeaning":{"publicId":"3447171","version":"1","preferredName":"Fallopian Tube Cancer pM1 TNM Finding v7","longName":"3447171","preferredDefinition":"Fallopian tube cancer with distant metastasis (excluding metastasis within the peritoneal cavity). (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fallopian Tube Cancer pM1 TNM Finding v7","conceptCode":"C89687","definition":"Fallopian tube cancer with distant metastasis (excluding metastasis within the peritoneal cavity). (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF0E27EF-C77E-7856-E040-BB89AD43436A","latestVersionIndicator":"Yes","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1BDB14A-1B85-57D2-E040-BB89AD437301","beginDate":"2012-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","deletedIndicator":"No"},{"value":"I","valueDescription":"Fallopian Tube Cancer pT1 TNM Finding v7","ValueMeaning":{"publicId":"3447125","version":"1","preferredName":"Fallopian Tube Cancer pT1 TNM Finding v7","longName":"3447125","preferredDefinition":"Fallopian tube cancer limited to fallopian tube(s). (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fallopian Tube Cancer pT1 TNM Finding v7","conceptCode":"C89670","definition":"Fallopian tube cancer limited to fallopian tube(s). (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF0DF04C-3359-36DC-E040-BB89AD432A18","latestVersionIndicator":"Yes","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1BDB14A-1B99-57D2-E040-BB89AD437301","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","deletedIndicator":"No"},{"value":"IA","valueDescription":"Fallopian Tube Cancer pT1a TNM Finding v7","ValueMeaning":{"publicId":"3447127","version":"1","preferredName":"Fallopian Tube Cancer pT1a TNM Finding v7","longName":"3447127","preferredDefinition":"Fallopian tube cancer with tumor limited to one tube, without penetrating the serosal surface; no ascites.  (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fallopian Tube Cancer pT1a TNM Finding v7","conceptCode":"C89671","definition":"Fallopian tube cancer with tumor limited to one tube, without penetrating the serosal surface; no ascites.  (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF0DF04C-337F-36DC-E040-BB89AD432A18","latestVersionIndicator":"Yes","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1BDB14A-1BAD-57D2-E040-BB89AD437301","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","deletedIndicator":"No"},{"value":"IB","valueDescription":"Fallopian Tube Cancer pT1b TNM Finding v7","ValueMeaning":{"publicId":"3447129","version":"1","preferredName":"Fallopian Tube Cancer pT1b TNM Finding v7","longName":"3447129","preferredDefinition":"Fallopian tube cancer with tumor limited to both tubes, without penetrating the serosal surface; no ascites. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fallopian Tube Cancer pT1b TNM Finding v7","conceptCode":"C89672","definition":"Fallopian tube cancer with tumor limited to both tubes, without penetrating the serosal surface; no ascites. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF0DF04C-33A5-36DC-E040-BB89AD432A18","latestVersionIndicator":"Yes","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1BDB14A-1BC1-57D2-E040-BB89AD437301","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","deletedIndicator":"No"},{"value":"IC","valueDescription":"Fallopian Tube Cancer pT1c TNM Finding v7","ValueMeaning":{"publicId":"3447131","version":"1","preferredName":"Fallopian Tube Cancer pT1c TNM Finding v7","longName":"3447131","preferredDefinition":"Fallopian tube cancer with tumor limited to one or both tubes with extension onto or through the tubal serosa, or with malignant cells in ascites or peritoneal washings. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fallopian Tube Cancer pT1c TNM Finding v7","conceptCode":"C89673","definition":"Fallopian tube cancer with tumor limited to one or both tubes with extension onto or through the tubal serosa, or with malignant cells in ascites or peritoneal washings. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF0DF04C-33CB-36DC-E040-BB89AD432A18","latestVersionIndicator":"Yes","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1BDB14A-1BD5-57D2-E040-BB89AD437301","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","deletedIndicator":"No"},{"value":"II","valueDescription":"Fallopian Tube Cancer pT2 TNM Finding v7","ValueMeaning":{"publicId":"3447133","version":"1","preferredName":"Fallopian Tube Cancer pT2 TNM Finding v7","longName":"3447133","preferredDefinition":"Fallopian tube cancer with tumor involving one or both fallopian tubes with pelvic extension. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fallopian Tube Cancer pT2 TNM Finding v7","conceptCode":"C89674","definition":"Fallopian tube cancer with tumor involving one or both fallopian tubes with pelvic extension. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF0DF04C-33F1-36DC-E040-BB89AD432A18","latestVersionIndicator":"Yes","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1BDB14A-1BE9-57D2-E040-BB89AD437301","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","deletedIndicator":"No"},{"value":"IIA","valueDescription":"Fallopian Tube Cancer pT2a TNM Finding v7","ValueMeaning":{"publicId":"3447135","version":"1","preferredName":"Fallopian Tube Cancer pT2a TNM Finding v7","longName":"3447135","preferredDefinition":"Fallopian tube cancer with extension and/or metastasis to the uterus and/or ovaries. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fallopian Tube Cancer pT2a TNM Finding v7","conceptCode":"C89675","definition":"Fallopian tube cancer with extension and/or metastasis to the uterus and/or ovaries. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF0DF04C-3417-36DC-E040-BB89AD432A18","latestVersionIndicator":"Yes","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1BDB14A-1BFD-57D2-E040-BB89AD437301","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","deletedIndicator":"No"},{"value":"IIB","valueDescription":"Fallopian Tube Cancer pT2b TNM Finding v7","ValueMeaning":{"publicId":"3447137","version":"1","preferredName":"Fallopian Tube Cancer pT2b TNM Finding v7","longName":"3447137","preferredDefinition":"Fallopian tube cancer with extension to other pelvic structures. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fallopian Tube Cancer pT2b TNM Finding v7","conceptCode":"C89676","definition":"Fallopian tube cancer with extension to other pelvic structures. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF0DF04C-343D-36DC-E040-BB89AD432A18","latestVersionIndicator":"Yes","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1BDB14A-1C11-57D2-E040-BB89AD437301","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","deletedIndicator":"No"},{"value":"IIC","valueDescription":"Fallopian Tube Cancer pT2c TNM Finding v7","ValueMeaning":{"publicId":"3447139","version":"1","preferredName":"Fallopian Tube Cancer pT2c TNM Finding v7","longName":"3447139","preferredDefinition":"Fallopian tube cancer with pelvic extension and malignant cells in ascites or peritoneal washings. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fallopian Tube Cancer pT2c TNM Finding v7","conceptCode":"C89677","definition":"Fallopian tube cancer with pelvic extension and malignant cells in ascites or peritoneal washings. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF0DF04C-3463-36DC-E040-BB89AD432A18","latestVersionIndicator":"Yes","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1BDB14A-1C25-57D2-E040-BB89AD437301","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","deletedIndicator":"No"},{"value":"III","valueDescription":"Fallopian Tube Cancer pT3 TNM Finding v7","ValueMeaning":{"publicId":"3447141","version":"1","preferredName":"Fallopian Tube Cancer pT3 TNM Finding v7","longName":"3447141","preferredDefinition":"Fallopian tube cancer with tumor involving one or both fallopian tubes, with peritoneal implants outside the pelvis. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fallopian Tube Cancer pT3 TNM Finding v7","conceptCode":"C89678","definition":"Fallopian tube cancer with tumor involving one or both fallopian tubes, with peritoneal implants outside the pelvis. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF0DF04C-3489-36DC-E040-BB89AD432A18","latestVersionIndicator":"Yes","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1BDB14A-1C39-57D2-E040-BB89AD437301","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","deletedIndicator":"No"},{"value":"IIIA","valueDescription":"Fallopian Tube Cancer pT3a TNM Finding v7","ValueMeaning":{"publicId":"3447143","version":"1","preferredName":"Fallopian Tube Cancer pT3a TNM Finding v7","longName":"3447143","preferredDefinition":"Fallopian tube cancer with microscopic peritoneal metastasis outside the pelvis. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fallopian Tube Cancer pT3a TNM Finding v7","conceptCode":"C89679","definition":"Fallopian tube cancer with microscopic peritoneal metastasis outside the pelvis. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF0DF04C-34AF-36DC-E040-BB89AD432A18","latestVersionIndicator":"Yes","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1BDB14A-1C4D-57D2-E040-BB89AD437301","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","deletedIndicator":"No"},{"value":"IIIB","valueDescription":"Fallopian Tube Cancer pT3b TNM Finding v7","ValueMeaning":{"publicId":"3447145","version":"1","preferredName":"Fallopian Tube Cancer pT3b TNM Finding v7","longName":"3447145","preferredDefinition":"Fallopian tube cancer with macroscopic peritoneal metastasis outside the pelvis 2 cm or less in greatest dimension. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fallopian Tube Cancer pT3b TNM Finding v7","conceptCode":"C89680","definition":"Fallopian tube cancer with macroscopic peritoneal metastasis outside the pelvis 2 cm or less in greatest dimension. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF0DF04C-34D5-36DC-E040-BB89AD432A18","latestVersionIndicator":"Yes","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1BDB14A-1C61-57D2-E040-BB89AD437301","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","deletedIndicator":"No"},{"value":"IIIC","valueDescription":"Fallopian Tube Cancer pT3c TNM Finding v7","ValueMeaning":{"publicId":"3447147","version":"1","preferredName":"Fallopian Tube Cancer pT3c TNM Finding v7","longName":"3447147","preferredDefinition":"Fallopian tube cancer with peritoneal metastasis outside the pelvis and more than 2 cm in diameter. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fallopian Tube Cancer pT3c TNM Finding v7","conceptCode":"C89681","definition":"Fallopian tube cancer with peritoneal metastasis outside the pelvis and more than 2 cm in diameter. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF0DF04C-34FB-36DC-E040-BB89AD432A18","latestVersionIndicator":"Yes","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1BDB14A-1C75-57D2-E040-BB89AD437301","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3474949","version":"1","preferredName":"Fallopian Tube Carcinoma Federation of Gynecology and Obstetrics Integer::2009 Stage","preferredDefinition":"A carcinoma arising from the fallopian tube which is attached to the uterine corpus (uterine body). Most patients are postmenopausal, and postmenopausal bleeding is the most frequently seen symptom. Morphologically, the majority of fallopian tube carcinomas are serous or endometrioid adenocarcinomas.:An international organization with a mission to promote the wellbeing of women and to raise the standards of practice in obstetrics and gynecology.  They are the creator of staging criteria to describe the extent and spread of gynecologic malignancies.:A number with no fractional part, including the negative and positive numbers as well as zero.::2009:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3474949v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fallopian Tube Carcinoma","conceptCode":"C3867","definition":"A carcinoma arising from the fallopian tube. Most patients are postmenopausal, and postmenopausal bleeding is the most frequently seen symptom. Morphologically, the majority of fallopian tube carcinomas are serous or endometrioid adenocarcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Federation of Gynecology and Obstetrics","conceptCode":"C89808","definition":"An international organization with a mission to promote the wellbeing of women and to raise the standards of practice in obstetrics and gynecology. They are the creator of staging criteria to describe the extent and spread of gynecologic malignancies.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1BDB14A-1B52-57D2-E040-BB89AD437301","latestVersionIndicator":"Yes","beginDate":"2012-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"FIGO:International Federal of Gynecology and Obstetrics","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1BDB14A-1B63-57D2-E040-BB89AD437301","latestVersionIndicator":"Yes","beginDate":"2012-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"COOPERM","dateModified":"2012-06-05","changeDescription":"Created for CRF standard harmonization. Released per request by D.Reeves. mc 6/5/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"3444896","version":"1","longName":"Fallopian Tube","context":"NCIP"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000586","version":"1","longName":"FIGO","context":"NCI Standards"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000689","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCI Standards"},{"publicId":"10000585","version":"1","longName":"FIGO","context":"NCI Standards"}]}],"AlternateNames":[{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"}],"ReferenceDocuments":[{"name":"FIGO Stage","type":"Preferred Question Text","description":"FIGO Stage","url":null,"context":"NCI Standards"}],"origin":"FIGO:International Federal of Gynecology and Obstetrics","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"C1BEC699-408B-9F9F-E040-BB89AD430971","latestVersionIndicator":"Yes","beginDate":"2012-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeDescription":"Created for CRF standard harmonization. Released per request by D.Reeves. mc 6/5/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}